References
- Berry C. C. A tutorial on confidence intervals for proportions in diagnostic radiology. AJR 1990; 154: 477
- Bousquet J.-C., Saini S., Stark D. D., et al. Characterization of a new paramagnetic complex. Radiology 1988; 166: 693
- Brasch R. C., Bennett H. F. Consideration in the choice of contrast media for MR imaging. Radiology 1988; 166: 897
- Cacheris W. P., Quay S. C., Rocklage S. M. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn. Reson. Imaging 1990; 8: 467
- Greco A., McNamara M. T., Lanthiez P., Quay S. C., Michelozzi G. Gadodiamide injection. Nonionic gadolinium chelate for MR imaging of the brain and spine — Phase II–III clinical trial. Radiology 1990; 176: 451
- Haustein J., Niendorf H.-P., Louton T. Dosage of Gd-DTPA in MR imaging of intracranial tumors. New developments in contrast agent research, P. A. Rinck, R. N. Muller. European Magnetic Resonance Forum, BlonaySwitzerland 1991; 66
- Henkes H., Schoerner W., Sander B., Felix R. MR imaging of the meninges. Magn. Reson. Imaging 1989; 7(Suppl. 1)4
- Le Mignon M.-M., Chambon C., Warrington S., Davies R., Bonnemain B. Pharmacokinetics and tolerability after intravenous injection into healthy volunteers. Invest. Radiol. 1990; 25: 933
- Mühler A., Saeed M., Wendland M. F., Brasch R. C., Higgins C. B. Non-ionic versus ionic MR contrast media. Hemodynamic studies. Society of Magnetic Resonance in Medicine, 10th Annual Meeting, San Francisco, 1991; 977
- Muraki A., Carvlin M., Francisco J., Rocklage S., Quay S. Gd-DTPA-BMA. Efficacy of a new MR contrast agent in cases of induced trauma and abscess. Magn. Reson. Imaging 1989; 7(Suppl. 1)3
- Niendorf H.-P., Laniado M., Semmler W., Schörner W., Felix R. Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors. AJNR 1987; 8: 803
- O'Toole M., VanWagoner M., Broschart J. L., Prasad R., Leese P. T., Quay S. C. Nonionic MRI contrast agents. A phase I clinical trial of the safety and tolerance of S-041 injection. Magn. Reson. Imaging 1989; 7(Suppl. 1)174
- Parizel P. M., Degryse H. R., Gheuens J., et al. Gadolinium DOTA enhanced MR imaging of intracranial lesions. J. Comput. Assist. Tomogr. 1989; 13: 378
- Rinck P. A. Safety of patients and personnel. Acute hazards. An introduction to magnetic resonance in medicine, P. A. Rinck, R. N. Muller, S. B. Petersen. Thieme Verlag, Stuttgart 1990; 99
- Runge V. M., Carollo B. R., Wolf C. R., Nelson K. L., Gelblum D. Y. Gd-DTPA. A review of clinical indication in central nervous system magnetic resonance imaging. Radio-Graphics 1989; 9: 929
- Tweedle M. F., Eaton S. M., Eckelman W. C., et al. Comparative chemical structure and pharmacokinetics of MRI contrast agents. Invest. Radiol. 1988; 23(Suppl. 1)236
- Van Wagoner M., Rocklage S. M. Gadodiamide injection, a nonionic MRI enhancement agent. Overview of development. New development in contrast agent research, P. A. Rinck, R. N. Muller. European Magnetic Resonance Forum, BlonaySwitzerland 1991; 49
- Weinmann H.-J., Press W. R., Radüchel B., Platzek J., Schmitt-Willich H., Vogler H. Characteristics of Gd-DTPA and new derivatives. Contrast media in MRI, C. Bydder, et al. International Workshop, Berlin 1990; 19, Bussum, the Netherlands 1990